{"database": "openregs", "table": "documents", "rows": [["FDA-2008-D-0118-0028", "FDA", "FDA-2008-D-0118", "Guidance for Industry on Diabetes Mellitus--Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes; Availability", "Notice", "NAD-Notice of Availability of Data", "2008-12-19T05:00:00Z", 2008, 12, "2008-12-19T05:00:00Z", null, "2008-12-23T23:31:51Z", "E8-30086", 0, 0, "09000064807e2c7c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2008-D-0118-0028"], "units": {}, "query_ms": 0.7521719671785831, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}